Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line [11]

Axel Grothey, Daniel Sargent

Research output: Contribution to journal › Letter › peer-review

233 Scopus citations

Fingerprint

Dive into the research topics of 'Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line [11]'. Together they form a unique fingerprint.